Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Journal of the American Chemical Society|March 18, 2005
Unusual heme-histidine bond in the active site of a chaperoneDonghan Lee, Konstantin Pervushin, Daniela Bischof, et al.Journal of Pain and Symptom Management|February 11, 2023
Telehospice for Cancer Patients Discharged from a Tertiary Care Hospital in Western KenyaKenneth Cornetta, Sarah Nyariki, Imran Manji, et al.Human Gene Therapy|October 13, 2005
Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detectionLakshmi Sastry, Yi Xu, Lisa Duffy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignanciesMichael J Robertson, David Pelloso, Rafat Abonour, et al.Microbiology (Reading, England)|August 1, 2008
Unmarked insertional mutagenesis in the bovine pathogen Mycoplasma mycoides subsp. mycoides SC: characterization of a lppQ mutantCarole Janis, Daniela Bischof, Géraldine Gourgues, et al.BMC Palliative Care|April 11, 2024
Impact of training on knowledge, confidence and attitude amongst community health volunteers in the provision of community-based palliative care in rural KenyaHussein Elias, Evelyne Kisembe, Sarah Nyariki, et al.Human Gene Therapy|September 22, 2011
Efficient large volume lentiviral vector production using flow electroporationScott R Witting, Lin-Hong Li, Aparna Jasti, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2010
Replication-competent lentivirus analysis of clinical grade vector productsKenneth Cornetta, Jing Yao, Aparna Jasti, et al.Stem Cells (Dayton, Ohio)|December 2, 2006
Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is notWen Tao, Barbara-Graham Evans, Jing Yao, et al.Cytotherapy|July 28, 2020
Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapiesMichael Scott, Dominic Clarke, Yonatan Lipsitz, et al.Pageof 10